title: Exon expression arrays as a tool to identify new cancer genes.
abstract: BACKGROUND
  Identification of genes that are causally implicated in oncogenesis is a major goal in cancer research. An estimated 10-20% of cancer-related gene mutations result in skipping of one or more exons in the encoded transcripts. Here we report on a strategy to screen in a global fashion for such exon-skipping events using PAttern based Correlation (PAC). The PAC algorithm has been used previously to identify differentially expressed splice variants between two predefined subgroups. As genetic changes in cancer are sample specific, we tested the ability of PAC to identify aberrantly expressed exons in single samples.
  
  
  RESULTS
  As a proof-of-principle, we tested the PAC strategy on human cancer samples of which the complete coding sequence of eight cancer genes had been screened for mutations. PAC detected all seven exon-skipping mutants among 12 cancer cell lines. PAC also identified exon-skipping mutants in clinical cancer specimens although detection was compromised due to heterogeneous (wild-type) transcript expression. PAC reduced the number of candidate genes/exons for subsequent mutational analysis by two to three orders of magnitude and had a substantial true positive rate. Importantly, of 112 randomly selected outlier exons, sequence analysis identified two novel exon skipping events, two novel base changes and 21 previously reported base changes (SNPs).
  
  
  CONCLUSIONS
  The ability of PAC to enrich for mutated transcripts and to identify known and novel genetic changes confirms its suitability as a strategy to identify candidate cancer genes.
authors.affiliation: Department of Medical Oncology, Josephine Nefkens Institute, Erasmus University Medical Center, Rotterdam, The Netherlands. a.schutte@erasmusmc.nl
authors.forename: Mieke
authors.initials: M
authors.lastname: Schutte
authors.forename: Fons
authors.initials: F
authors.lastname: Elstrodt
authors.forename: Linda B C
authors.initials: LB
authors.lastname: Bralten
authors.forename: Jord H A
authors.initials: JH
authors.lastname: Nagel
authors.forename: Elza
authors.initials: E
authors.lastname: Duijm
authors.forename: Antoinette
authors.initials: A
authors.lastname: Hollestelle
authors.forename: Maartje J
authors.initials: MJ
authors.lastname: Vuerhard
authors.forename: Marijke
authors.initials: M
authors.lastname: Wasielewski
authors.forename: Justine K
authors.initials: JK
authors.lastname: Peeters
authors.forename: Peter
authors.initials: P
authors.lastname: van der Spek
authors.forename: Peter A
authors.initials: PA
authors.lastname: Sillevis Smitt
authors.forename: Pim J
authors.initials: PJ
authors.lastname: French
mesh_terms: D001483:Base Sequence; D001943:Breast Neoplasms / Q000235:genetics*; D045744:Cell Line, Tumor; D002471:Cell Transformation, Neoplastic / Q000235:genetics; D005091:Exons / Q000235:genetics*; D005260:Female; D015870:Gene Expression; D020869:Gene Expression Profiling; D052138:Genes, Neoplasm; D005828:Genetics, Population; D006801:Humans; D020411:Oligonucleotide Array Sequence Analysis; D051059:PTEN Phosphohydrolase / Q000235:genetics; D020641:Polymorphism, Single Nucleotide; D014158:Transcription, Genetic
chemical_list: D051059:PTEN Phosphohydrolase